THE ROLE OF AROMATASE INHIBITORS IN POLYCYSTIC OVARY SYNDROME

dc.contributor.author	Azimova Bahtigul Jovli kizi
dc.date.accessioned	2026-01-12T20:33:01Z
dc.date.issued	2026-01-12
dc.description.abstract	Polycystic Ovary Syndrome (PCOS) is one of the most common endocrine disorders affecting women of reproductive age and represents a major cause of anovulatory infertility. The syndrome is characterized by hyperandrogenism, ovulatory dysfunction, and polycystic ovarian morphology, often accompanied by metabolic disturbances such as insulin resistance and obesity. Ovulation induction remains a central component in the management of infertility associated with PCOS.
dc.format	application/pdf
dc.identifier.uri	https://webofjournals.com/index.php/5/article/view/5820
dc.identifier.uri	https://asianeducationindex.com/handle/123456789/110643
dc.language.iso	eng
dc.publisher	Web of Journals Publishing
dc.relation	https://webofjournals.com/index.php/5/article/view/5820/5842
dc.rights	https://creativecommons.org/licenses/by-nc-nd/4.0
dc.source	Web of Medicine: Journal of Medicine, Practice and Nursing ; Vol. 4 No. 1 (2026): WOM; 86-89
dc.source	2938-3765
dc.subject	Polycystic ovary syndrome; aromatase inhibitors; letrozole; ovulation induction; infertility.
dc.title	THE ROLE OF AROMATASE INHIBITORS IN POLYCYSTIC OVARY SYNDROME
dc.type	info:eu-repo/semantics/article
dc.type	info:eu-repo/semantics/publishedVersion
dc.type	Peer-reviewed Article

item.page.files

pagination.showing.labelpagination.showing.detail

item.page.filesection.name: kizi_2026_the_role_of_aromatase_inhibitors_in_poly.pdf
item.page.filesection.size: 296.45 KB
item.page.filesection.format: Adobe Portable Document Format